Huang, Jue http://orcid.org/0000-0003-1830-9340
Ahlers, Eike
Bogatsch, Holger
Böhme, Pierre
Ethofer, Thomas
Fallgatter, Andreas J.
Gallinat, Jürgen
Hegerl, Ulrich
Heuser, Isabella
Hoffmann, Knut
Kittel-Schneider, Sarah
Reif, Andreas
Schöttle, Daniel
Unterecker, Stefan
Gärtner, Matti
Strauß, Maria
Funding for this research was provided by:
Universität Leipzig
Article History
Received: 18 February 2022
Accepted: 12 June 2022
First Online: 4 July 2022
Declarations
:
: MS has received speaker’s fees from Lilly, MEDICE Arzneimittel Pütter GmbH & Co. KG, Servier and was an advisory board member for Shire/Takeda. AR has received speaker’s honoraria and/or served on advisory boards for MEDICE, Shire/Takeda, Janssen, neuraxpharm, Sevier and SAGE. SKS received author’s, speaker’s and consultant’s honoraria from MEDICE and Shire/Takeda. EA was an advisory board member for Shire/Takeda. JG has received research funding from the German Federal Ministry of Education and Research, German Science Foundation, and speaker fees from Sanofi, Lundbeck, Janssen-Cilag, Lilly and Otsuka. UH has received funding from, and was a consultant for MEDICE and an advisory board member for Janssen-Cilag. The other authors do not report any possible conflicts of interest.
: This study was carried according to the Declaration of Helsinki and the Guideline for Good Clinical Practice. This study was proved by local ethics committee of the University of Leipzig (337/15-ff). All participants signed an informed consent.